BUSINESS WIRE

New investigational combination telmisartan and amlodipine shows effective and well-tolerated 24-hour blood pressure control in hypertensive patients at risk of cardiovascular events

Loading media player...
Prof. Ettore Ambrosioni, Italy: The Real Cost of the Wrong Treatment.

Embed